Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women

Antonia Hoeg, Apostolos Gogakos, Elaine Murphy, Sandra Mueller, Josef Köhrle, David M. Reid, Claus C. Glüer, Dieter Felsenberg, Christian Roux, Richard Eastell, Lutz Schomburg*, Graham R. Williams

*Corresponding author for this work

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Context: Selenium status may have direct effects on bone and indirect effects through changes in thyroid hormone sensitivity. Objective: We hypothesized that variation in selenium status in healthy euthyroid postmenopausal women is associated with differences in bone turnover, bone mineral density (BMD) and fracture susceptibility. Design: The Osteoporosis and Ultrasound Study (OPUS) is a 6-yr prospective study of fracture-related factors. Setting: The study was comprised of a population-based cohort from five European cities. Participants: A total of 2374 postmenopausal women participated. Subjects with thyroid disease and nonthyroidal illness and those receiving drugs affecting thyroid status or bone metabolism were excluded, leaving a study population of 1144. Interventions: There were no interventions. Main Outcome Measures: We measured selenium (micrograms per liter); selenoprotein P (milligrams per liter); free T4 (picomoles per liter); free T3 (picomoles per liter); TSH (milliunits per liter); bone turnover markers; BMD; and vertebral, hip, and nonvertebral fractures. Results: Higher selenium levels were associated with higher hip BMD at study entry (β = 0.072, P = 0.004) and lower levels of bone formation (osteocalcin: β = -0.101, P < 0.001; procollagen type 1 N-terminal propeptide: β = -0.074, P = 0.013) and resorption markers (C-telopeptide of type 1 collagen: β = -0.058, P = 0.050; N-telopeptide of type 1 collagen: β = -0.095, P = 0.002). Higher selenoprotein P was associated with higher hip (β = 0.113, P < 0.001) and lumbar spine BMD (β = 0.088, P = 0.003) at study entry, higher hip BMD after the 6-yr follow-up (β = 0.106, P = 0.001) and lower osteocalcin (β = -0.077, P = 0.009), C-telopeptide of type 1 collagen (β = -0.075, P = 0.012), and N-telopeptide of type 1 collagen (β = -0.110, P < 0.001). Conclusion: Selenium status is inversely related to bone turnover and positively correlated with BMD in healthy euthyroid postmenopausal women independent of thyroid status.

Original languageEnglish
Pages (from-to)4061-4070
Number of pages10
JournalJournal of Clinical Endocrinology and Metabolism
Volume97
Issue number11
Early online date17 Aug 2012
DOIs
Publication statusPublished - 1 Nov 2012

Fingerprint

Bone Remodeling
Selenium
Bone Density
Minerals
Collagen Type I
Bone
Bone and Bones
Selenoprotein P
Pelvic Bones
Osteocalcin
Thyroid Gland
Thyroid Diseases
Bone Fractures
Hip Fractures
Thyroid Hormones
Osteogenesis
Population
Osteoporosis
Hip
Spine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. / Hoeg, Antonia; Gogakos, Apostolos; Murphy, Elaine; Mueller, Sandra; Köhrle, Josef; Reid, David M.; Glüer, Claus C.; Felsenberg, Dieter; Roux, Christian; Eastell, Richard; Schomburg, Lutz; Williams, Graham R.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 97, No. 11, 01.11.2012, p. 4061-4070.

Research output: Contribution to journalArticle

Hoeg, A, Gogakos, A, Murphy, E, Mueller, S, Köhrle, J, Reid, DM, Glüer, CC, Felsenberg, D, Roux, C, Eastell, R, Schomburg, L & Williams, GR 2012, 'Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women', Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 11, pp. 4061-4070. https://doi.org/10.1210/jc.2012-2121
Hoeg, Antonia ; Gogakos, Apostolos ; Murphy, Elaine ; Mueller, Sandra ; Köhrle, Josef ; Reid, David M. ; Glüer, Claus C. ; Felsenberg, Dieter ; Roux, Christian ; Eastell, Richard ; Schomburg, Lutz ; Williams, Graham R. / Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women. In: Journal of Clinical Endocrinology and Metabolism. 2012 ; Vol. 97, No. 11. pp. 4061-4070.
@article{a90f2eabbc4f4246918075638132d3fa,
title = "Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women",
abstract = "Context: Selenium status may have direct effects on bone and indirect effects through changes in thyroid hormone sensitivity. Objective: We hypothesized that variation in selenium status in healthy euthyroid postmenopausal women is associated with differences in bone turnover, bone mineral density (BMD) and fracture susceptibility. Design: The Osteoporosis and Ultrasound Study (OPUS) is a 6-yr prospective study of fracture-related factors. Setting: The study was comprised of a population-based cohort from five European cities. Participants: A total of 2374 postmenopausal women participated. Subjects with thyroid disease and nonthyroidal illness and those receiving drugs affecting thyroid status or bone metabolism were excluded, leaving a study population of 1144. Interventions: There were no interventions. Main Outcome Measures: We measured selenium (micrograms per liter); selenoprotein P (milligrams per liter); free T4 (picomoles per liter); free T3 (picomoles per liter); TSH (milliunits per liter); bone turnover markers; BMD; and vertebral, hip, and nonvertebral fractures. Results: Higher selenium levels were associated with higher hip BMD at study entry (β = 0.072, P = 0.004) and lower levels of bone formation (osteocalcin: β = -0.101, P < 0.001; procollagen type 1 N-terminal propeptide: β = -0.074, P = 0.013) and resorption markers (C-telopeptide of type 1 collagen: β = -0.058, P = 0.050; N-telopeptide of type 1 collagen: β = -0.095, P = 0.002). Higher selenoprotein P was associated with higher hip (β = 0.113, P < 0.001) and lumbar spine BMD (β = 0.088, P = 0.003) at study entry, higher hip BMD after the 6-yr follow-up (β = 0.106, P = 0.001) and lower osteocalcin (β = -0.077, P = 0.009), C-telopeptide of type 1 collagen (β = -0.075, P = 0.012), and N-telopeptide of type 1 collagen (β = -0.110, P < 0.001). Conclusion: Selenium status is inversely related to bone turnover and positively correlated with BMD in healthy euthyroid postmenopausal women independent of thyroid status.",
author = "Antonia Hoeg and Apostolos Gogakos and Elaine Murphy and Sandra Mueller and Josef K{\"o}hrle and Reid, {David M.} and Gl{\"u}er, {Claus C.} and Dieter Felsenberg and Christian Roux and Richard Eastell and Lutz Schomburg and Williams, {Graham R.}",
note = "Acknowledgements We thank Jennifer Suhr and Susann Herrmann (ICI-Immunochemical Intelligence GmbH, Berlin, Germany) for help with the measurement of SePP concentrations. We also thank Immunodiagnostic Systems for support for the PTH and 25-hydroxyvitamin D measurements.",
year = "2012",
month = "11",
day = "1",
doi = "10.1210/jc.2012-2121",
language = "English",
volume = "97",
pages = "4061--4070",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women

AU - Hoeg, Antonia

AU - Gogakos, Apostolos

AU - Murphy, Elaine

AU - Mueller, Sandra

AU - Köhrle, Josef

AU - Reid, David M.

AU - Glüer, Claus C.

AU - Felsenberg, Dieter

AU - Roux, Christian

AU - Eastell, Richard

AU - Schomburg, Lutz

AU - Williams, Graham R.

N1 - Acknowledgements We thank Jennifer Suhr and Susann Herrmann (ICI-Immunochemical Intelligence GmbH, Berlin, Germany) for help with the measurement of SePP concentrations. We also thank Immunodiagnostic Systems for support for the PTH and 25-hydroxyvitamin D measurements.

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Context: Selenium status may have direct effects on bone and indirect effects through changes in thyroid hormone sensitivity. Objective: We hypothesized that variation in selenium status in healthy euthyroid postmenopausal women is associated with differences in bone turnover, bone mineral density (BMD) and fracture susceptibility. Design: The Osteoporosis and Ultrasound Study (OPUS) is a 6-yr prospective study of fracture-related factors. Setting: The study was comprised of a population-based cohort from five European cities. Participants: A total of 2374 postmenopausal women participated. Subjects with thyroid disease and nonthyroidal illness and those receiving drugs affecting thyroid status or bone metabolism were excluded, leaving a study population of 1144. Interventions: There were no interventions. Main Outcome Measures: We measured selenium (micrograms per liter); selenoprotein P (milligrams per liter); free T4 (picomoles per liter); free T3 (picomoles per liter); TSH (milliunits per liter); bone turnover markers; BMD; and vertebral, hip, and nonvertebral fractures. Results: Higher selenium levels were associated with higher hip BMD at study entry (β = 0.072, P = 0.004) and lower levels of bone formation (osteocalcin: β = -0.101, P < 0.001; procollagen type 1 N-terminal propeptide: β = -0.074, P = 0.013) and resorption markers (C-telopeptide of type 1 collagen: β = -0.058, P = 0.050; N-telopeptide of type 1 collagen: β = -0.095, P = 0.002). Higher selenoprotein P was associated with higher hip (β = 0.113, P < 0.001) and lumbar spine BMD (β = 0.088, P = 0.003) at study entry, higher hip BMD after the 6-yr follow-up (β = 0.106, P = 0.001) and lower osteocalcin (β = -0.077, P = 0.009), C-telopeptide of type 1 collagen (β = -0.075, P = 0.012), and N-telopeptide of type 1 collagen (β = -0.110, P < 0.001). Conclusion: Selenium status is inversely related to bone turnover and positively correlated with BMD in healthy euthyroid postmenopausal women independent of thyroid status.

AB - Context: Selenium status may have direct effects on bone and indirect effects through changes in thyroid hormone sensitivity. Objective: We hypothesized that variation in selenium status in healthy euthyroid postmenopausal women is associated with differences in bone turnover, bone mineral density (BMD) and fracture susceptibility. Design: The Osteoporosis and Ultrasound Study (OPUS) is a 6-yr prospective study of fracture-related factors. Setting: The study was comprised of a population-based cohort from five European cities. Participants: A total of 2374 postmenopausal women participated. Subjects with thyroid disease and nonthyroidal illness and those receiving drugs affecting thyroid status or bone metabolism were excluded, leaving a study population of 1144. Interventions: There were no interventions. Main Outcome Measures: We measured selenium (micrograms per liter); selenoprotein P (milligrams per liter); free T4 (picomoles per liter); free T3 (picomoles per liter); TSH (milliunits per liter); bone turnover markers; BMD; and vertebral, hip, and nonvertebral fractures. Results: Higher selenium levels were associated with higher hip BMD at study entry (β = 0.072, P = 0.004) and lower levels of bone formation (osteocalcin: β = -0.101, P < 0.001; procollagen type 1 N-terminal propeptide: β = -0.074, P = 0.013) and resorption markers (C-telopeptide of type 1 collagen: β = -0.058, P = 0.050; N-telopeptide of type 1 collagen: β = -0.095, P = 0.002). Higher selenoprotein P was associated with higher hip (β = 0.113, P < 0.001) and lumbar spine BMD (β = 0.088, P = 0.003) at study entry, higher hip BMD after the 6-yr follow-up (β = 0.106, P = 0.001) and lower osteocalcin (β = -0.077, P = 0.009), C-telopeptide of type 1 collagen (β = -0.075, P = 0.012), and N-telopeptide of type 1 collagen (β = -0.110, P < 0.001). Conclusion: Selenium status is inversely related to bone turnover and positively correlated with BMD in healthy euthyroid postmenopausal women independent of thyroid status.

UR - http://www.scopus.com/inward/record.url?scp=84868611193&partnerID=8YFLogxK

U2 - 10.1210/jc.2012-2121

DO - 10.1210/jc.2012-2121

M3 - Article

C2 - 22904175

AN - SCOPUS:84868611193

VL - 97

SP - 4061

EP - 4070

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -